Search for other papers by Kristin Ottarsdottir in
Google Scholar
PubMed
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Anna G Nilsson in
Google Scholar
PubMed
Search for other papers by Margareta Hellgren in
Google Scholar
PubMed
Search for other papers by Ulf Lindblad in
Google Scholar
PubMed
Search for other papers by Bledar Daka in
Google Scholar
PubMed
baseline was 47.3 years ( s.d. 11.4), and at follow-up the mean age was 57.7 years ( s.d. 11.6). Further characteristics of the study population at baseline and follow-up are presented in Table 1 . In the cross-sectional analyses, concentrations of total
Search for other papers by Robert I Menzies in
Google Scholar
PubMed
Search for other papers by Xin Zhao in
Google Scholar
PubMed
Search for other papers by Linda J Mullins in
Google Scholar
PubMed
Search for other papers by John J Mullins in
Google Scholar
PubMed
Search for other papers by Carolynn Cairns in
Google Scholar
PubMed
Search for other papers by Nicola Wrobel in
Google Scholar
PubMed
Search for other papers by Donald R Dunbar in
Google Scholar
PubMed
Search for other papers by Matthew A Bailey in
Google Scholar
PubMed
Search for other papers by Christopher J Kenyon in
Google Scholar
PubMed
expression of beta-actin and 18S ribosomal RNA. Neither 18S RNA nor beta-actin was affected by ACTH treatment. Statistics Data are presented as mean ± s.e. After tests for Gaussian distribution, comparisons were made using either unpaired t -test
Search for other papers by Herjan J T Coelingh Bennink in
Google Scholar
PubMed
Search for other papers by Jan Krijgh in
Google Scholar
PubMed
Search for other papers by Jan F M Egberts in
Google Scholar
PubMed
Search for other papers by Maria Slootweg in
Google Scholar
PubMed
Search for other papers by Harm H E van Melick in
Google Scholar
PubMed
Search for other papers by Erik P M Roos in
Google Scholar
PubMed
Search for other papers by Diederik M Somford in
Google Scholar
PubMed
Search for other papers by Yvette Zimmerman in
Google Scholar
PubMed
Search for other papers by Iman J Schultz in
Google Scholar
PubMed
Search for other papers by Noel W Clarke in
Google Scholar
PubMed
Search for other papers by R Jeroen A van Moorselaar in
Google Scholar
PubMed
Search for other papers by Frans M J Debruyne in
Google Scholar
PubMed
) after 24 weeks of treatment with 40 mg estetrol or placebo daily co-administration in patients with prostate cancer treated with an LHRH agonist ( 25 ). Results are reported as mean ( s.d. ). Laboratory parameter Percentage change from
Search for other papers by A C Paepegaey in
Google Scholar
PubMed
Search for other papers by M Coupaye in
Google Scholar
PubMed
Search for other papers by A Jaziri in
Google Scholar
PubMed
Search for other papers by F Ménesguen in
Google Scholar
PubMed
Search for other papers by B Dubern in
Google Scholar
PubMed
Search for other papers by M Polak in
Google Scholar
PubMed
Search for other papers by J M Oppert in
Google Scholar
PubMed
Search for other papers by M Tauber in
Google Scholar
PubMed
Search for other papers by G Pinto in
Google Scholar
PubMed
INSERM, UMRS 1166, Nutriomic Group 6, Paris, France
Sorbonne Université, UMRS1166, Paris, France
Search for other papers by C Poitou in
Google Scholar
PubMed
) 37 Young J Couzinet B Nahoul K Brailly S Chanson P Baulieu EE Schaison G . Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans . Journal of Clinical Endocrinology and Metabolism 1997 82
Alfred Health, Melbourne, Victoria, Australia
Search for other papers by Pravik Solanki in
Google Scholar
PubMed
Department of General Practice, Melbourne Medical School, The University of Melbourne, Victoria, Australia
Search for other papers by Beng Eu in
Google Scholar
PubMed
Search for other papers by Jeremy Smith in
Google Scholar
PubMed
Search for other papers by Carolyn Allan in
Google Scholar
PubMed
Search for other papers by Kevin Lee in
Google Scholar
PubMed
– ✓ Trenbolone acetate Finaplix H, Finaplix S, Parabolan C 20 H 24 O 3 PO, IM, pellets – ✓ Drostanolone propionate Masteron C 23 H 36 O 3 IM – – Information sources: trade names ( 18 ), formula ( 18 , 19 ), route
Search for other papers by Liza Haqq in
Google Scholar
PubMed
Search for other papers by James McFarlane in
Google Scholar
PubMed
Search for other papers by Gudrun Dieberg in
Google Scholar
PubMed
Search for other papers by Neil Smart in
Google Scholar
PubMed
resistance and hyperinsulinaemia, but these two features are also present in lean women with PCOS (5, 6) . Hormonal manifestations include elevated levels of androgens (testosterone, DHEA and androstenedione), oestrogens and prolactin. Occasionally, thyroid
Search for other papers by Marcus Imamovic in
Google Scholar
PubMed
Search for other papers by Nils Bäcklund in
Google Scholar
PubMed
Search for other papers by Staffan Lundstedt in
Google Scholar
PubMed
Search for other papers by Göran Brattsand in
Google Scholar
PubMed
Search for other papers by Elisabeth Aardal in
Google Scholar
PubMed
Search for other papers by Tommy Olsson in
Google Scholar
PubMed
Search for other papers by Per Dahlqvist in
Google Scholar
PubMed
.1007/s12020-013-0013-0 ) 13 Al-Dujaili EA Kenyon CJ Nicol MR Mason JI . Liquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone levels in vivo and in vitro by inhibiting adrenal SULT2A1 activity . Molecular and Cellular
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by M Guftar Shaikh in
Google Scholar
PubMed
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Search for other papers by Timothy G Barrett in
Google Scholar
PubMed
Search for other papers by Nicola Bridges in
Google Scholar
PubMed
Search for other papers by Robin Chung in
Google Scholar
PubMed
Centre for Endocrinology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK
Search for other papers by Evelien F Gevers in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
Search for other papers by Anthony P Goldstone in
Google Scholar
PubMed
Search for other papers by Anthony Holland in
Google Scholar
PubMed
Search for other papers by Shankar Kanumakala in
Google Scholar
PubMed
Search for other papers by Ruth Krone in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Makarios Children's Hospital, Nicosia, Cyprus
Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed
Sussex Community NHS Trust, Brighton, UK
Search for other papers by E Anne Livesey in
Google Scholar
PubMed
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by Angela K Lucas-Herald in
Google Scholar
PubMed
Search for other papers by Christina Meade in
Google Scholar
PubMed
Search for other papers by Susan Passmore in
Google Scholar
PubMed
The University of Dublin, Trinity College Dublin, Dublin, Republic of Ireland
Search for other papers by Edna Roche in
Google Scholar
PubMed
Search for other papers by Chris Smith in
Google Scholar
PubMed
Search for other papers by Sarita Soni in
Google Scholar
PubMed
, but small in adulthood ( 116 ). Generally, boys with PWS have a normal appearance and development of pubic hair, reflecting unimpaired adrenal androgen secretion, and normal androstenedione and dehydroepiandrosterone sulphate (DHEAS) concentrations